248 related articles for article (PubMed ID: 34311471)
1. Role of Lipogenesis Rewiring in Hepatocellular Carcinoma.
Zhou Y; Tao J; Calvisi DF; Chen X
Semin Liver Dis; 2022 Feb; 42(1):77-86. PubMed ID: 34311471
[TBL] [Abstract][Full Text] [Related]
2. Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.
Jia J; Che L; Cigliano A; Wang X; Peitta G; Tao J; Zhong S; Ribback S; Evert M; Chen X; Calvisi DF
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187130
[TBL] [Abstract][Full Text] [Related]
3. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
[TBL] [Abstract][Full Text] [Related]
4. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
Yu X; Lin Q; Wu Z; Zhang Y; Wang T; Zhao S; Song X; Chen C; Wang Z; Xu L; Li C; Gao L; Liang X; Yue X; Ma C
J Pathol; 2020 Dec; 252(4):358-370. PubMed ID: 32770671
[TBL] [Abstract][Full Text] [Related]
5. Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis.
Meng H; Shen M; Li J; Zhang R; Li X; Zhao L; Huang G; Liu J
Eur J Pharmacol; 2021 Sep; 906():174280. PubMed ID: 34174265
[TBL] [Abstract][Full Text] [Related]
6. Sortilin-Driven Cancer Secretome Enhances Tumorigenic Properties of Hepatocellular Carcinoma via de Novo Lipogenesis.
Chan KK; Au KY; Suen LH; Leung B; Wong CY; Leow WQ; Lim TK; Ng IO; Chung CY; Lo RC
Am J Pathol; 2023 Dec; 193(12):2156-2171. PubMed ID: 37673328
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.
Li L; Pilo GM; Li X; Cigliano A; Latte G; Che L; Joseph C; Mela M; Wang C; Jiang L; Ribback S; Simile MM; Pascale RM; Dombrowski F; Evert M; Semenkovich CF; Chen X; Calvisi DF
J Hepatol; 2016 Feb; 64(2):333-341. PubMed ID: 26476289
[TBL] [Abstract][Full Text] [Related]
8. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in genes of the de novo lipogenesis pathway and overall survival of hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Wu YS; Bao DK; Dai JY; Chen C; Zhang HX; Yang Y; Xing JL; Huang XJ; Wan SG
Asian Pac J Cancer Prev; 2015; 16(3):1051-6. PubMed ID: 25735330
[TBL] [Abstract][Full Text] [Related]
10. [(11)C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in Mice.
Li L; Che L; Wang C; Blecha JE; Li X; VanBrocklin HF; Calvisi DF; Puchowicz M; Chen X; Seo Y
Mol Imaging Biol; 2016 Jun; 18(3):360-7. PubMed ID: 26567114
[TBL] [Abstract][Full Text] [Related]
11. Sperm associated antigen 4 promotes SREBP1-mediated de novo lipogenesis via interaction with lamin A/C and contributes to tumor progression in hepatocellular carcinoma.
Liu T; Yu J; Ge C; Zhao F; Chen J; Miao C; Jin W; Zhou Q; Geng Q; Lin H; Tian H; Chen T; Xie H; Cui Y; Yao M; Xiao X; Li J; Li H
Cancer Lett; 2022 Jun; 536():215642. PubMed ID: 35307486
[TBL] [Abstract][Full Text] [Related]
12. USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638.
Ni W; Lin S; Bian S; Zheng W; Qu L; Fan Y; Lu C; Xiao M; Zhou P
Cell Death Dis; 2020 Oct; 11(10):843. PubMed ID: 33040080
[TBL] [Abstract][Full Text] [Related]
13. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
Bai PS; Xia N; Sun H; Kong Y
J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
[TBL] [Abstract][Full Text] [Related]
14. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617
[TBL] [Abstract][Full Text] [Related]
15. Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Min X; Wen J; Zhao L; Wang K; Li Q; Huang G; Liu J; Zhao X
Mol Oncol; 2018 Sep; 12(9):1480-1497. PubMed ID: 30004626
[TBL] [Abstract][Full Text] [Related]
16. Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma.
Che L; Pilo MG; Cigliano A; Latte G; Simile MM; Ribback S; Dombrowski F; Evert M; Chen X; Calvisi DF
Cell Cycle; 2017 Mar; 16(6):499-507. PubMed ID: 28118080
[TBL] [Abstract][Full Text] [Related]
17. DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.
Feng T; Li S; Zhao G; Li Q; Yuan H; Zhang J; Gu R; Ou D; Guo Y; Kou Q; Wang Q; Li K; Lin P
Cell Oncol (Dordr); 2023 Oct; 46(5):1235-1252. PubMed ID: 37052853
[TBL] [Abstract][Full Text] [Related]
18. The IKKβ-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis.
Gu L; Zhu Y; Lin X; Lu B; Zhou X; Zhou F; Zhao Q; Prochownik EV; Li Y
Hepatology; 2021 Jan; 73(1):160-174. PubMed ID: 32221968
[TBL] [Abstract][Full Text] [Related]
19. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Carcinoma-Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element-Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth.
Wang C; Tong Y; Wen Y; Cai J; Guo H; Huang L; Xu M; Feng M; Chen X; Zhang J; Wu H; Kong X; Xia Q
Hepatology; 2018 Nov; 68(5):1833-1850. PubMed ID: 29663480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
